Option for Commercial License. 4.1 Carnegie Mellon hereby grants to Licensee the option (“Option”) to negotiate an exclusive license from Carnegie Mellon to manufacture, use, sell, lease or otherwise dispose of products and/or services based on, in whole or in part, the technology and intellectual property comprised in the Carnegie Mellon Materials and to practice under the Patent for exosome and cellular therapeutic applications.
Appears in 3 contracts
Samples: Transfer Agreement (Coya Therapeutics, Inc.), Coya Therapeutics, Inc., Coya Therapeutics, Inc.
Option for Commercial License. 4.1 Carnegie Mellon hereby grants to Licensee the option (“Option”) to request to negotiate [an exclusive or a non-exclusive] commercial license from Carnegie Mellon to manufacture, use, sell, lease or otherwise dispose of products and/or services based on, in whole or in part, the technology and intellectual property comprised in the Carnegie Mellon Materials Technology and to practice under the Patent for exosome and cellular therapeutic applicationsPatent.
Appears in 1 contract
